203 related articles for article (PubMed ID: 37744296)
1. Regenerating gene 4 promotes chemoresistance of colorectal cancer by affecting lipid droplet synthesis and assembly.
Zhang CY; Zhang R; Zhang L; Wang ZM; Sun HZ; Cui ZG; Zheng HC
World J Gastroenterol; 2023 Sep; 29(35):5104-5124. PubMed ID: 37744296
[TBL] [Abstract][Full Text] [Related]
2. The effects of REG4 expression on chemoresistance of ovarian cancer.
Xiang LW; Xue H; Ha MW; Yu DY; Xiao LJ; Zheng HC
J Obstet Gynaecol; 2022 Oct; 42(7):3149-3157. PubMed ID: 35929918
[TBL] [Abstract][Full Text] [Related]
3. Reg4-induced mitogenesis involves Akt-GSK3β-β-Catenin-TCF-4 signaling in human colorectal cancer.
Bishnupuri KS; Sainathan SK; Bishnupuri K; Leahy DR; Luo Q; Anant S; Houchen CW; Dieckgraefe BK
Mol Carcinog; 2014 Feb; 53 Suppl 1(0 1):E169-80. PubMed ID: 24151146
[TBL] [Abstract][Full Text] [Related]
4. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism.
Dai W; Xiang W; Han L; Yuan Z; Wang R; Ma Y; Yang Y; Cai S; Xu Y; Mo S; Li Q; Cai G
Cancer Commun (Lond); 2022 Sep; 42(9):848-867. PubMed ID: 35904817
[TBL] [Abstract][Full Text] [Related]
5. The promoting effects of GPR176 expression on proliferation, chemoresistance, lipogenesis and invasion of oesophageal cancer.
Yun WJ; Li J; Yin NC; Zhang CY; Cui ZG; Zhang L; Zheng HC
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14641-14655. PubMed ID: 37584712
[TBL] [Abstract][Full Text] [Related]
6. REG4 acts as a mitogenic, motility and pro-invasive factor for colon cancer cells.
Rafa L; Dessein AF; Devisme L; Buob D; Truant S; Porchet N; Huet G; Buisine MP; Lesuffleur T
Int J Oncol; 2010 Mar; 36(3):689-98. PubMed ID: 20126989
[TBL] [Abstract][Full Text] [Related]
7. The facilitating effects of KRT80 on chemoresistance, lipogenesis, and invasion of esophageal cancer.
Yun WJ; Li J; Yin NC; Zhang CY; Cui ZG; Zhang L; Zheng HC
Cancer Biol Ther; 2024 Dec; 25(1):2302162. PubMed ID: 38241178
[TBL] [Abstract][Full Text] [Related]
8. REG4 independently predicts better prognosis in non-mucinous colorectal cancer.
Kaprio T; Hagström J; Mustonen H; Koskensalo S; Andersson LC; Haglund C
PLoS One; 2014; 9(10):e109600. PubMed ID: 25295732
[TBL] [Abstract][Full Text] [Related]
9. Prothymosin α promotes colorectal carcinoma chemoresistance through inducing lipid droplet accumulation.
Jin L; Zhu LY; Pan YL; Fu HQ; Zhang J
Mitochondrion; 2021 Jul; 59():123-134. PubMed ID: 33872798
[TBL] [Abstract][Full Text] [Related]
10. REG4 promotes peritoneal metastasis of gastric cancer through GPR37.
Wang H; Hu L; Zang M; Zhang B; Duan Y; Fan Z; Li J; Su L; Yan M; Zhu Z; Liu B; Yang Q
Oncotarget; 2016 May; 7(19):27874-88. PubMed ID: 27036049
[TBL] [Abstract][Full Text] [Related]
11. Reg4 Interacts with CD44 to Regulate Proliferation and Stemness of Colorectal and Pancreatic Cancer Cells.
Bishnupuri KS; Sainathan SK; Ciorba MA; Houchen CW; Dieckgraefe BK
Mol Cancer Res; 2022 Mar; 20(3):387-399. PubMed ID: 34753802
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer.
Zhu X; Han Y; Yuan C; Tu W; Qiu G; Lu S; Lu H; Peng Z; Zhou C
Oncol Rep; 2015 Jan; 33(1):320-8. PubMed ID: 25338725
[TBL] [Abstract][Full Text] [Related]
13. The ménage à trois of autophagy, lipid droplets and liver disease.
Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
[TBL] [Abstract][Full Text] [Related]
14. Kruppel-like factor 5 enhances proliferation, lipid droplet formation and oxaliplatin resistance in colorectal cancer by promoting fatty acid binding protein 6 transcription.
Zuo Q; Xu Q; Li Z; Luo D; Peng H; Duan Z
Anticancer Drugs; 2023 Nov; 34(10):1171-1182. PubMed ID: 37067981
[TBL] [Abstract][Full Text] [Related]
15. FAM64A aggravates proliferation, invasion, lipid droplet formation, and chemoresistance in gastric cancer: A biomarker for aggressiveness and a gene therapy target.
Yun WJ; Zhang L; Yang N; Cui ZG; Jiang HM; Ha MW; Yu DY; Zhao MZ; Zheng HC
Drug Dev Res; 2023 Nov; 84(7):1537-1552. PubMed ID: 37571819
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer.
Li N; Chen M; Cao Y; Li H; Zhao J; Zhai Z; Ren F; Li K
BMC Cancer; 2018 Aug; 18(1):793. PubMed ID: 30081850
[TBL] [Abstract][Full Text] [Related]
17. The bioinformatics analysis of the clinicopathological and prognostic significances of REG4 mRNA in gynecological cancers.
Zhang CY; Zhang L; Wang ZM; Ren DH; Zheng HC
J Obstet Gynaecol; 2023 Dec; 43(1):2213764. PubMed ID: 37218920
[TBL] [Abstract][Full Text] [Related]
18. REG4 promotes the proliferation and anti-apoptosis of cancer.
Zheng HC; Xue H; Zhang CY
Front Cell Dev Biol; 2022; 10():1012193. PubMed ID: 36172286
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide.
Novoa Díaz MB; Carriere P; Gigola G; Zwenger AO; Calvo N; Gentili C
World J Gastroenterol; 2022 Jul; 28(26):3177-3200. PubMed ID: 36051345
[TBL] [Abstract][Full Text] [Related]
20. JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing β-catenin signaling pathway.
Wu X; Li R; Song Q; Zhang C; Jia R; Han Z; Zhou L; Sui H; Liu X; Zhu H; Yang L; Wang Y; Ji Q; Li Q
J Exp Clin Cancer Res; 2019 Oct; 38(1):435. PubMed ID: 31665047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
